Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Michel Hotton

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Therapie|September 22, 2010
Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European levelDriss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
The American Journal of Psychiatry|May 4, 2004
A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorderJean-Pierre Lépine, Vincent Caillard, Jean-Claude Bisserbe, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Therapie|September 22, 2010
Comparators (medicinal and non medicinal) for marketing authorization, for public health, for payers and at the European levelDriss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
Therapie|July 10, 2016
[Not Available]Driss Berdaï, Jean-Michel Hotton, Philippe Lechat, et al.
The American Journal of Psychiatry|May 4, 2004
A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorderJean-Pierre Lépine, Vincent Caillard, Jean-Claude Bisserbe, et al.
Pageof 1